PULMATRIX, INC. Total Long-Term Debt
PULMATRIX, INC. (PULM) had Total Long-Term Debt of $6.40 million as of 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2016-11-04
- 2016-09-30: Long-term Debt $6.40M.
- 2016-06-30: Long-term Debt $31.00K.
- 2016-03-31: Long-term Debt $31.00K.
- 2015-09-30: Long-term Debt $6.73M.
| Period end | Long-term Debt |
|---|---|
| 2016-09-30 | $6.40M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $31.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $31.00K 10-Q · filed 2016-05-05 |
| 2015-09-30 | $6.73M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $6.71M 10-Q · filed 2015-08-14 |
| 2014-12-31 | $39.70M 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |